WE.SPEED.
ARENSIA invites you to an exclusive 90 min. online session focusing on the thriving clinical trials landscape in Ukraine.
Ukraine is witnessing a resurgence of activities from major pharmaceutical and biotech firms, involving both ongoing and new studies. This aligns with the broader strategy of large pharmaceutical corporations, aiming to enhance inclusivity and extend their reach to underserved populations.
In an effort to stimulate clinical trial activities, Ukrainian Health Authorities have recently streamlined legislation, notably reducing the overall approval timeline to just 35 days.
Kyiv remains a secure hub for clinical trials, with all systems operating seamlessly for over a year, including local on-site monitoring, laboratories, courier services, and vendors for imaging.
Despite the conflict starting in February 2022, ARENSIA clinics in downtown Kyiv have maintained full operations, achieving exceptional patient enrollment rates while ensuring data quality and safety.
Join us for insights from esteemed speakers representing Health Authorities, Sponsors, global CROs, and logistics companies on launching and managing clinical trials in Ukraine.